News Pfizer leukaemia drug accepted by NICE Bosulif is first drug to be funded following reassessment.
Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
News Medivation in merger talks with Sanofi and others Sources say Pfizer and Celgene are also interested.
News BIND accepts Pfizer bid following bankruptcy Bid of $20 million may be enough to acquire all of BIND's assets.
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
